- Doximity ( NYSE: DOCS ) is up 24% in Friday morning trading as it benefits from fiscal 2023 Q2 earnings beats and a strong fiscal year revenue forecast .
- The company is projecting fiscal 2023 revenue of $424M-$432M. The consensus estimate is $426.36M.
- Several Street firms raised their price targets Friday. Evercore ISI's Elizabeth Anderson, who has an in line rating, raised her target to $32 from $28 (~22% upside based on Thursday's close). However, in light of the macro environment, she sees Doximity ( DOCS ) having a risk of facing pharma budget headwinds going into the latter half of fiscal 2023.
- Wells Fargo's Stan Berenshteyn, who has an outperform rating, raised his target to $44 from $38 (~67% upside).
- Seeking Alpha's Quant Rating views Doximity ( DOCS ) as a hold.
For further details see:
Doximity continues surge, up 24% following quarterly results